Figure 1.
Figure 1A,B. Schema comparing SA-biotin multistep pretargeted radioimmunotherapy (PRIT) (A) and 2H7-Fc-C825 bispecific FP PRIT (B). Infusion of the anti-CD20 construct is followed by injection of a synthetic CA (N-acetylgalactosamine or DOTAY-dextran) and then infusion of the radiolabeled small molecule.